Website
http://dataportal.arc.gov.au/NCGP/API/grants/DE190100985
Funding Status
Closed
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Funded Activity Summary
Targeted genome editing using engineered CRISPR-Cas endonucleases. This project aims to study the generation of targeted and cell-specific endonucleases. CRISPR-Cas endonucleases have revolutionised the field of genome engineering due to programming simplicity based on a short guide RNA and high cleavage efficiency. This project will combine the use of two technologies in genome engineering and antibody therapeutics to generate new antibody-targeted endonucleases that modify cellular genomes with high efficacy and specificity. This project will provide new and intriguing insights into cellar function, with broad applications in basic research and biotechnology.Funded Activity Details
Start Date: 04-2019
End Date: 01-2022
Funding Scheme: Discovery Early Career Researcher Award
Funding Amount: $409,574.00
Funder: Australian Research Council
Research Topics
ANZSRC Field of Research (FoR)
Medical Biotechnology | Medical Molecular Engineering of Nucleic Acids and Proteins
